Hester Biosciences (BOM:524669) Institutional Ownership: 11.42% (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524669 Hester Biosciences Ltd BOM:524669
77 GF Score
Price ₹2,186.40
GF Value ₹1,884.58
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hester Biosciences Institutional Ownership?

Hester Biosciences BOM:524669 -2.31% 77 Institutional Ownership is 11.42% as of Sep. 22, 2026. GuruFocus rates BOM:524669 with a GF Score™ of 77/100 and a GF Value™ of ₹1,884.58 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hester Biosciences's institutional ownership is 11.42%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hester Biosciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hester Biosciences's Float Percentage Of Total Shares Outstanding is 0.00%.

Hester Biosciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Hester Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hester Biosciences Institutional Ownership Chart

Hester Biosciences Historical Data

The historical data trend for Hester Biosciences can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-07-31 2026-08-31
Institutional Ownership 11.84 11.85 11.84 11.76 11.49 11.47 11.44 11.42 11.39 11.42
BOM:524669
77GF Score
Hester Biosciences Ltd BOM:524669
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hester Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 11.42% mean?
Hester Biosciences (BOM:524669) has a Institutional Ownership of 11.42% as of Sep. 22, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Hester Biosciences and its competitors.
Is Hester Biosciences' Institutional Ownership too high?
Hester Biosciences' current Institutional Ownership is 11.42%. Overall, Hester Biosciences has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hester Biosciences' Institutional Ownership compare to ZTS?
Hester Biosciences' Institutional Ownership of 11.42% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Hester Biosciences and its competitors. Hester Biosciences's current Institutional Ownership is 11.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hester Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Hester Biosciences (BOM:524669) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,884.58, compared to a current price of ₹2,186.40 — trading 16% above its estimated fair value. The current Institutional Ownership is 11.42%. Hester Biosciences' overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Hester Biosciences (BOM:524669), the current Institutional Ownership is 11.42% as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hester Biosciences (BOM:524669) Overvalued in 2026?

Based on GuruFocus' analysis, Hester Biosciences stock appears to be overvalued. The current stock price of ₹2,186.40 is trading 16% above its estimated GF Value™ of ₹1,884.58. GuruFocus considers Hester Biosciences to be Modestly Overvalued.

Key valuation signals for BOM:524669:

  • Institutional Ownership: 11.42%
  • GF Value™: ₹1,884.58 vs. price of ₹2,186.40 (16% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the BOM:524669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hester Biosciences Business Description

Other Exchanges HESTERBIO:India
Address Village Meda - Adraj, Taluka Kadi, District Mehsana, Mehsana, GJ, IND, 384441
Hester Biosciences Ltd is an India-based animal healthcare company. It is principally engaged in the manufacturing of veterinary vaccines and trading of veterinary health products such as goat pox vaccine, PPR vaccines, etc. The group has two principal operating and reporting segments, viz. Poultry healthcare and Animal healthcare. Maximum revenue is generated from the Poultry Healthcare segment, which offers various solutions encompassing vaccines, health products, and feed supplements, supported and packaged by its diagnostic services, R&D, quality standards, and field support, to help farmers protect flock health, enhance productivity, and drive long-term farm sustainability. Geographically, it generates maximum revenue within India, and also exports its products to other markets.
77GF Score

Get the complete analysis for BOM:524669

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,186.40
Price
₹1,884.58
GF Value